Additional file 2 of Challenges in diagnosis and management of neutropenia upon exposure to immune-checkpoint inhibitors: meta-analysis of a rare immune-related adverse side effect

Authors :: J. Boegeholz
C. S. Brueggen
C. Pauli
F. Dimitriou
E. Haralambieva
R. Dummer
M. G. Manz
C. C. Widmer
Publication Year :: 2020
Publisher :: figshare, 2020.
Abstract: Additional file 2. Kaplan-Meier curves for duration of neutropenia in days in a patient subpopulation Diseases (A) ICI Treatment (B) other immune-related adverse events = irAE (C). Neutropenia therapy with steroids (D), IVIG (+ Steroids) (E) and other secondary salvage therapy (+/− IVIG) (F). Significance threshold was defined as

Full Text Access

Tools